About this trial

While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical knowledge effectively, making AI recommendations explainable to clinicians, and establishing safety guarantees.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • AI-PERSONALIZED CLINICAL DECISION SUPPORT

Treatment groups

300,000 Participants
are divided into 3 treatment groups

Locations

1
Hospital of the University of Pennsylvania19104, PhiladelphiaPennsylvania, United States

Sponsors and collaborators

Abramson Cancer Center at Penn Medicine

Lead sponsor